Претраживање
Приказ резултата 11-20 од 39
Human mesenchymal stem cells creating an immunosuppressive environment and promote breast cancer in mice
(Nature Publishing Group, London, 2013)
Human mesenchymal stem cells (hMSC) can home to tumor sites and promote tumor growth. The effects of hMSC on tumor growth are controversial and involvement of hMSC in tumor immunology has not been adequately addressed. ...
Proinflammatory cytokine il-6 stimulation of angiogenic factors and DNA replication is blocked by jak-stat pathway inhibition in myeloproliferative neoplasms
(Ferrata Storti Foundation, Pavia, 2017)
A prognostic model to predict thrombosis in essential thrombocythemia
(Ferrata Storti Foundation, Pavia, 2014)
Gene and protein expression analyses of the mtor signaling pathway in myeloproliferative neoplasms
(Ferrata Storti Foundation, Pavia, 2015)
Factors associated with Toxoplasma gondii infection in confined farrow-to-finish pig herds in western France: an exploratory study in 60 herds
(Biomed Central Ltd, London, 2016)
Background: Infection by Toxoplasma gondii postnatally can occur after ingestion of contaminated meat or water (tissue cysts/oocysts). In Europe, percentage of meat borne infections is estimated between 30 and 63 %, out ...
Proangiogenetic molecules vegf, hif-1alpha and enos in myeloproliferative neoplasms
(Ferrata Storti Foundation, Pavia, 2013)
Cd38 and interleukin 6 gene polymorphism in b-cell chronic lymphocytic leukemia-correlation with clinical and laboratory parametars
(Ferrata Storti Foundation, Pavia, 2016)
JAK2-mutant hematopoietic cells display metabolic alterations that can be targeted to treat myeloproliferative neoplasms
(Amer Soc Hematology, Washington, 2019)
Increased energy requirement and metabolic reprogramming are hallmarks of cancer cells. We show that metabolic alterations in hematopoietic cells are fundamental to the pathogenesis of mutant JAK2-driven myeloproliferative ...
Monitoring of leukocyte-platelet aggregates and selectin levels in patients with philadelphia-negative myeloproliferative neoplasms
(Ferrata Storti Foundation, Pavia, 2017)
Predictors of survival in patients with essential thrombocythemia
(Ferrata Storti Foundation, Pavia, 2015)